ABL Bio Inc. (298380.KQ)

KRW 27400.0

(-5.03%)

Total Assets Summary of ABL Bio Inc.

  • ABL Bio Inc.'s latest annual total assets in 2023 was 160.14 Billion KRW , down -13.52% from previous year.
  • ABL Bio Inc.'s latest quarterly total assets in 2024 Q2 was 120.71 Billion KRW , down -14.24% from previous quarter.
  • ABL Bio Inc. reported annual total assets of 185.18 Billion KRW in 2022, up 182.92% from previous year.
  • ABL Bio Inc. reported annual total assets of 65.45 Billion KRW in 2021, down -34.48% from previous year.
  • ABL Bio Inc. reported quarterly total assets of 120.71 Billion KRW for 2024 Q2, down -14.24% from previous quarter.
  • ABL Bio Inc. reported quarterly total assets of 202.9 Billion KRW for 2023 Q1, up 9.57% from previous quarter.

Annual Total Assets Chart of ABL Bio Inc. (2023 - 2016)

Historical Annual Total Assets of ABL Bio Inc. (2023 - 2016)

Year Total Assets Total Assets Growth
2023 160.14 Billion KRW -13.52%
2022 185.18 Billion KRW 182.92%
2021 65.45 Billion KRW -34.48%
2020 99.89 Billion KRW -30.1%
2019 142.9 Billion KRW -15.38%
2018 168.86 Billion KRW 729.02%
2017 20.36 Billion KRW 170.5%
2016 7.53 Billion KRW 0.0%

Peer Total Assets Comparison of ABL Bio Inc.

Name Total Assets Total Assets Difference
Sam Chun Dang Pharm. Co., Ltd 408.02 Billion KRW 60.751%
Hyundai Bioscience Co., Ltd. 52.79 Billion KRW -203.351%
ST Pharm Co.,Ltd. 686.83 Billion KRW 76.684%
Cellid, Co., Ltd. 63.92 Billion KRW -150.53%